UPDATE: Neurocrine Bio. (NBIX) PT Lowered to $95 at Mizuho Securities
Tweet Send to a Friend
(Updated - February 14, 2022 8:55 AM EST)
Mizuho Securities analyst Vamil Divan lowered the price target ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Mizuho Securities analyst Vamil Divan lowered the price target ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
